Oxford Uni spin-out Zegami seeks NHS X-rays for COVID-19 diagnosticA digital tool that could improve coronavirus diagnosis and guide treatment decisions has been developed by Oxford University Share XOxford Uni spin-out Zegami seeks NHS X-rays for COVID-19 diagnostichttps://pharmaphorum.com/news/oxford-uni-spin-out-zegami-seeks-nhs-x-rays-for-covid-19-diagnostic/
US backs first emergency COVID-19 antibody test from CellexThe FDA has given its first approval to Cellex for a COVID-19 test that can detect whether someone Share XUS backs first emergency COVID-19 antibody test from Cellexhttps://pharmaphorum.com/news/us-backs-first-emergency-covid-19-antibody-test-from-cellex/
Apeiron starts mid-stage trial of drug that blocks coronavirusApeiron Biologics has been cleared to start a European phase 2 trial of a drug that it says Share XApeiron starts mid-stage trial of drug that blocks coronavirushttps://pharmaphorum.com/news/apeiron-starts-mid-stage-trial-of-drug-that-blocks-coronavirus/
Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianA leading UK scientist says some drugmakers are acting like “supermarket hoarders” as coronavirus escalates, failing to share Share XSome pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianhttps://pharmaphorum.com/news/some-pharmas-acting-like-toilet-roll-profiteers-on-covid-19-says-clinician/
Antitrust delay scuppers Novartis’ $1bn generics sale to AurobindoNovartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a Share XAntitrust delay scuppers Novartis’ $1bn generics sale to Aurobindohttps://pharmaphorum.com/news/antitrust-delay-scuppers-novartis-1bn-generics-sale-to-aurobindo/
FDA says all ranitidine drugs should be recalled on safety concernsThe FDA has asked drugmakers to pull all prescription and over-the-counter products based on ranitidine off the market Share XFDA says all ranitidine drugs should be recalled on safety concernshttps://pharmaphorum.com/news/fda-says-all-ranitidine-drugs-should-be-recalled-on-safety-concerns/
As COVID-19 deaths leap, UK mulls use of contact tracing appScientists have urged the UK government to deploy an app that alerts people who have been in contact Share XAs COVID-19 deaths leap, UK mulls use of contact tracing apphttps://pharmaphorum.com/news/as-covid-19-deaths-leap-uk-mulls-use-of-contact-tracing-app/
Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trialMallinckrodt and Novoteris have been given a green light by Health Canada to start a pilot study of Share XMallinckrodt, Novoteris’ nitric oxide will start COVID-19 trialhttps://pharmaphorum.com/news/mallinckrodt-novoteris-nitric-oxide-will-start-covid-19-trial/
Free telemedicine service in UK will connect patients to at-home doctorsA free virtual consultation service has been set up in the UK to link worried patients with healthcare Share XFree telemedicine service in UK will connect patients to at-home doctorshttps://pharmaphorum.com/news/free-telemedicine-service-in-uk-will-connect-patients-to-at-home-doctors/
